Oxygen-controlled three-dimensional cultures to analyze tumor angiogenesis

Tissue Engineering - Part A

Volumn 16, Issue 7, 2010, Pages 2133-2141

  Verbridge, Scott S ^a   Choi, Nak Won ^a   Zheng, Ying ^a   Brooks, Daniel J ^a   Stroock, Abraham D ^a   Fischbach, Claudia ^a  

^a Cornell University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; ENDOTHELIAL CELLS; OXYGEN; SELF ASSEMBLY; TUMORS;

AMBIENT CONDITIONS; ANTI-CANCER THERAPIES; EXTRACELLULAR MATRIX INTERACTIONS; GLIOBLASTOMA CELLS; INTEGRINS; INTERLEUKIN-8; MICRO-SCALES; OXYGEN CONCENTRATIONS; QUALITATIVE DIFFERENCES; SQUAMOUS CELL CARCINOMA; THREE-DIMENSIONAL (3D); THREE-DIMENSIONAL CULTURE; TUMOR ANGIOGENESIS; TUMOR MODELS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

THREE DIMENSIONAL;

ALGINIC ACID; ANGIOGENIC FACTOR; GLUCURONIC ACID; HEXURONIC ACID; OXYGEN;

ARTICLE; BIOLOGICAL MODEL; CELL COMMUNICATION; CULTURE TECHNIQUE; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VASCULARIZATION;

ALGINATES; ANGIOGENESIS INDUCING AGENTS; CELL COMMUNICATION; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; EXTRACELLULAR MATRIX; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; SIGNAL TRANSDUCTION;

EID: 77954522750     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0670     Document Type: Article

References (41)

1. Hanahan, D., and Weinberg, R.A. The hallmarks of cancer. Cell 100, 57, 2000.
2. Bergers, G., and Benjamin, L.E. Tumorigenesis and the an-giogenic switch. Nat Rev Cancer 3, 401, 2003.
3. Harris, A.L. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2, 38, 2002.
4. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D., and Semenza, G.L. Activation of vascular en-dothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16, 4604, 1996.
5. Maxwell, P.H., Dachs, G.U., Gleadle, J.M., Nicholls, L.G., Harris, A.L., Stratford, I.J., Hankinson, O., Pugh, C.W., and Ratcliffe, P.J. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogene-sis and tumor growth. PNAS 94, 8104, 1997.
6. Folkman, J., Bach, M., Rowe, J.W., Davidoff, F., Lambert, P., Hirsch, C., Goldberg, A., Hiatt, H.H., Glass, J., and Hen-shaw, E. Tumor angiogenesis-therapeutic implications. N Engl J Med 285, 1182, 1971.
7. Kerbel, R.S. Molecular origins of cancer: tumor angiogenesis. N Engl J Med 358, 2039, 2008.
8. Folkman, J., and Klagsbrun, M. Angiogenic factors. Science 235, 442, 1987.
9. Bissell, M.J., and Radisky, D. Putting tumours in context. Nat Rev Cancer 1, 46, 2001.
10. Ingber, D.E. Can cancer be reversed by engineering the tumor microenvironment? Semin Cancer Biol 18, 356, 2008.
11. Fischbach, C., Chen, R., Matsumoto, T., Schmelzle, T., Brugge, J.S., Polverini, P.J., and Mooney, D.J. Engineering tumors with 3D scaffolds. Nat Methods 4, 855, 2007.
12. Fischbach, C., Kong, H.J., Hsiong, S.X., Evangelista, M.B., Yuen, W., and Mooney, D.J. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci USA 106, 399, 2009.
13. Jain, R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58, 2005.
14. Mizukami, Y., Jo, W.S., Duerr, E.M., Gala, M., Li, J.N., Zhang, X.B., Zimmer, M.A., Iliopoulos, O., Zukerberg, L.R., Kohgo, Y., Lynch, M.P., Rueda, B.R., and Chung, D.C. Induction of interleukin-8 preserves the angiogenic response in HIF-1 alpha-deficient colon cancer cells. Nat Med 11, 992, 2005.
15. Casanovas, O., Hicklin, D.J., Bergers, G., and Hanahan, D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8, 299, 2005.
16. Lal, A., Peters, H., St. Croix, B., Haroon, Z.A., Dewhirst, M.W., Strausberg, R.L., Kaanders, J., van der Kogel, A.J., and Riggins, G.J. Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93, 1337, 2001.
17. Richard, D.E., Berra, E., and Pouyssegur, J. Angiogenesis: how a tumor adapts to hypoxia. Biochem Biophys Res Commun 266, 718, 1999.
18. Zhong, H., De Marzo, A.M., Laughner, E., Lim, M., Hilton, D.A., Zagzag, D., Buechler, P., Isaacs, W.B., Semenza, G.L., and Simons, J.W. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Res 59, 5830, 1999.
19. Semenza, G.L. Involvement of hypoxia-inducible factor 1 in human cancer. Intern Med 41, 79, 2002.
20. Pampaloni, F., Reynaud, E.G., and Stelzer, E.H.K. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8, 839, 2007.
21. Albrecht, D.R., Underhill, G.H., Wassermann, T.B., Sah, R.L., and Bhatia, S.N. Probing the role of multicellular organization in three-dimensional microenvironments. Nat Methods 3, 369, 2006.
22. Lee, G.Y., Kenny, P.A., Lee, E.H., and Bissell, M.J. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 4, 359, 2007.
23. Choi, N.W., Cabodi, M., Held, B., Gleghorn, J.P., Bonassar, L.J., and Stroock, A.D. Microfluidic scaffolds for tissue engineering. Nat Mater 6, 908, 2007.
24. Heywood, H.K., Sembi, P.K., Lee, D.A., and Bader, D.L. Cellular utilization determines viability and matrix distribution profiles in chondrocyte-seeded alginate constructs. Tissue Eng 10, 1467, 2004.
25. Cheema, U., Brown, R.A., Alp, B., and MacRobert, A.J. Spatially defined oxygen gradients and vascular endothelial growth factor expression in an engineered 3D cell model. Cell Mol Life Sci 65, 177, 2008.
26. Rowley, J.A., Madlambayan, G., and Mooney, D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20, 45, 1999.
27. Fursov, N., Cong, M., Federici, M., Platchek, M., Haytko, P., Tacke, R., Livelli, T., and Zhong, Z. Improving consistency of cell-based assays by using division-arrested cells. Assay Drug Dev Technol 3, 7, 2005.
28. Spaeth, E.E., and Friedlander, S.K. Diffusion of oxygen carbon dioxide and inert gas in flowing blood. Biophys J 7, 827, 1967.
29. Ruffieux, P.A., von Stockar, U., and Marison, I.W. Measurement of volumetric (OUR) and determination of specific (qO(2)) oxygen uptake rates in animal cell cultures. J Bio-technol 63, 85, 1998.
30. Muellerklieser, W., Zander, R., and Vaupel, P. A new photometric-method for oxygen-consumption measurements in cell-suspensions. J Appl Physiol 61, 449, 1986.
31. Zhang, Y., Lu, H., Dazin, P., and Kapila, Y. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis-Fibronectin and integrin alpha(v) mediate survival signals through focal adhesion kinase. J Biol Chem 279, 48342, 2004.
32. Simpson-Haidaris, P.J., and Rybarczyk, B. Tumors and fibrinogen-the role of fibrinogen as an extracellular matrix protein. In: Nieuwenhuizen, W., Mosesson, M.W., and De-Maat, M.P.M., eds. Proceedings paper from Annals of the New York Academy of Sciences, vol.936. New York: New York Academy of Sciences, 2001, pp. 406-425.
33. Kumar, R., Kuniyasu, H., Bucana, C.D., Wilson, M.R., and Fidler, I.J. Spatial and temporal expression of angiogenic molecules during tumor growth and progression. Oncol Res 10, 301, 1998.
34. Skuli, N., Monferran, S., Delmas, C., Favre, G., Bonnet, J., Toulas, C., and Moyal, E.C.J. Alpha(v)beta(3)=alpha(v) beta(5) integrins-FAK-RhoB: a novel pathway for hyp-oxia regulation in glioblastoma. Cancer Res 69, 3308, 2009.
35. Xie, K.P. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12, 375, 2001.
36. Waugh, D.J.J., and Wilson, C. The interleukin-8 pathway in cancer. Clin Cancer Res 14, 6735, 2008.
37. Yuan, A., Chen, J.J.W., Yao, P.L., and Yang, P.C. The role of interleukin-8 in cancer cells and microenvironment interaction. Front Biosci 10, 853, 2005.
38. Tan, C.P., Seo, B.R., Brooks, D.J., Chandler, E.M., Craighead, H.G., and Fischbach, C. Parylene peel-off arrays to probe the role of cell-cell interactions in tumour angiogenesis. Integr Biol 1, 587, 2009.
39. Cavallaro, U., Liebner, S., and Dejana, E. Endothelial cad-herins and tumor angiogenesis. Exp Cell Res 312, 659, 2006.
40. Simon, M.C., and Keith, B. The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol 9, 285, 2008.
41. Hockel, M., and Vaupel, P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93, 266, 2001.